Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Rigel Pharmaceuticals, Inc. RIGL

Set alert

Price alert · RIGL

All alert types
50.53 USD -0.78 -1.52%

At close · Nov 2

50.53 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
50.48 × 1
Ask
50.54 × 1
50.00 Day range 51.84
24.95 52-week range 52.61
YTD
+17.98%
1 year
+60.01%
Open
51.33
Prev close
51.31
Mkt cap
943.89M
Vol
136.05K
Avg vol
259.24K
EPS
16.88
P/E
2.99
Div yield
0.00%
More statistics
Low
50.00
High
51.84
Forward P/E
19.49
Beta
0.95
Short ratio
1.69
Inst. own
68.01%
Dividend
0.00
Ex-div date
50-d avg
20.01
200-d avg
13.77
1y target
31.33

5D chart

Chart tools
Interval
1m5m15m30m

Signals (115)
NameTimeAgo
SMA: BearishNov 2, 3:55 PM15 hours ago
SMA: BearishNov 2, 3:55 PM15 hours ago
MACD: Sell SignalNov 2, 3:55 PM15 hours ago
MACD: Buy SignalNov 2, 3:45 PM15 hours ago
SMA: BullishNov 2, 3:40 PM15 hours ago
SMA: BullishNov 2, 3:40 PM15 hours ago
SMA: BearishNov 2, 3:35 PM15 hours ago
MACD: Sell SignalNov 2, 3:35 PM15 hours ago
SMA: BearishNov 2, 3:30 PM15 hours ago
SMA: BearishNov 2, 3:15 PM15 hours ago
SMA: BullishNov 2, 2:40 PM16 hours ago
SMA: BearishNov 2, 2:25 PM16 hours ago
SMA: BullishNov 2, 2:15 PM16 hours ago
SMA: BearishNov 2, 2:05 PM16 hours ago
SMA: BullishNov 2, 1:55 PM17 hours ago
SMA: BearishNov 2, 1:40 PM17 hours ago
SMA: BearishNov 2, 1:20 PM17 hours ago
SMA: BullishNov 2, 12:50 PM18 hours ago
SMA: BullishNov 2, 12:30 PM18 hours ago
SMA: BearishNov 2, 12:25 PM18 hours ago

Newest 20 of 115.

Analyst view

Consensus: buy

Buy
Price target (mean) 31.33 -38.0% downside
Target (low)
14.00
Target (mean)
31.33
Target (high)
57.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 6
  • 2 months ago 6
  • 3 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RIGL analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.334010.13 – 0.590.000.0%47.42M+32.5%5
Next quarter0.180.18 – 0.18-0.50+136.0%43.49M+47.3%1
Current year0.240860.09 – 0.37-1.40+117.2%169.10M+44.7%5
Next year1.040.53 – 1.610.24086+331.4%193.51M+14.4%5

Upgrades and downgrades

The latest rating changes

RIGL analyst upgrades and downgrades
DateFirmActionFromTo
Dec 10, 2024Cantor FitzgeraldMaintainedNeutralNeutral
Dec 10, 2024B. Riley SecuritiesMaintainedNeutralNeutral
Dec 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 6, 2024B. Riley SecuritiesMaintainedNeutralNeutral
Nov 14, 2024Piper SandlerMaintainedNeutralNeutral
Nov 12, 2024CitigroupMaintainedBuyBuy
Oct 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 9, 2024HC Wainwright & Co.MaintainedBuyBuy
Jun 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 3, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 7, 2024CitigroupMaintainedBuyBuy
Mar 6, 2024Cantor FitzgeraldMaintainedNeutralNeutral
Mar 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 6, 2024B. Riley SecuritiesMaintainedNeutralNeutral
Feb 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jan 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 8, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 2, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 3, 2023HC Wainwright & Co.Reiterated—Buy
Mar 9, 2023CitigroupMaintained—Buy
Mar 8, 2023HC Wainwright & Co.Reiterated—Buy
Dec 2, 2022CitigroupUpgradeNeutralBuy
Nov 4, 2022BMO CapitalMaintained—Outperform
Aug 18, 2022HC Wainwright & Co.Maintained—Buy
Aug 17, 2022Piper SandlerMaintained—Neutral
Jun 9, 2022BMO CapitalMaintained—Outperform
Jun 9, 2022B. Riley SecuritiesMaintained—Neutral
Jun 9, 2022CitigroupDowngradeBuyNeutral